GF-DUAL 10mg

GF-DUAL 10 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation.

For research use only — not for human or veterinary use.

Product Overview

GF-DUAL 10 mg is a synthetic peptide research compound manufactured to high analytical standards for use in controlled scientific investigations. The compound is supplied in a lyophilized form to maximise stability during storage while allowing controlled preparation for laboratory experimentation.

Each production batch undergoes comprehensive independent third-party laboratory analysis to verify assay content, peptide purity, identity, microbiological quality, bacterial endotoxin levels and elemental impurities. This analytical approach provides researchers with transparent batch-specific documentation that supports reproducibility and quality assurance.

This preparation contains 10 mg of lyophilized peptide. Independent analytical testing confirmed an assay content of 10.22 mg for the analysed batch, exceeding the labelled content while maintaining chromatographic purity greater than 99.8 percent.

With independently verified analytical quality and complete Certificate of Analysis documentation, GF-DUAL provides researchers with a highly characterised peptide suitable for controlled laboratory and in vitro investigations.

Peptide Overview

GF-DUAL is a research peptide investigated within controlled laboratory environments involving peptide biology, receptor interactions, intracellular signalling and molecular communication pathways.

Researchers utilise compounds of this class in experimental models designed to investigate peptide-mediated signalling mechanisms, biochemical regulation and molecular interactions under carefully controlled laboratory conditions.

Modern analytical verification allows each production batch to be characterised through complementary analytical techniques including chromatographic purity analysis, FTIR spectroscopy and retention time verification, providing multiple independent confirmation points for compound identity and quality.

Its consistent analytical profile and comprehensive batch-specific verification make GF-DUAL suitable for advanced peptide research where reproducibility and traceability are essential.

Historical Background and Scientific Context

Advances in peptide synthesis and analytical chemistry have significantly improved the quality control of research-grade peptide compounds. Today, independent laboratory verification allows researchers to evaluate not only peptide purity, but also assay content, identity, microbiological quality, endotoxin levels and elemental impurities.

Modern chromatographic techniques, infrared spectroscopy and microbiological testing provide a comprehensive analytical profile that supports laboratory reproducibility and transparent quality documentation.

GF-DUAL is produced according to these modern analytical standards and independently evaluated by Liquilabs s.r.o. Czechia using validated laboratory methodologies.

This multi-parameter analytical approach provides researchers with substantially more information than purity testing alone and allows every production batch to be fully documented before release.

Mechanistic Focus in Research

Within controlled laboratory environments, GF-DUAL may be investigated in relation to peptide-mediated signalling pathways and molecular communication systems.

Research investigations may include:

• Peptide signalling pathway investigations
• Receptor interaction studies
• Intracellular communication research
• Cellular regulatory pathway analysis
• Molecular biology investigations
• Comparative peptide research
• Controlled biochemical studies
• In vitro peptide experimentation

These applications refer exclusively to controlled scientific investigation performed within appropriate laboratory environments.

Analytical Verification (COA)

This batch of GF-DUAL has undergone comprehensive independent laboratory testing performed by Liquilabs s.r.o. Czechia. The analytical programme evaluates peptide content, chromatographic purity, identity, microbiological quality, bacterial endotoxin levels and elemental impurities.

Batch: GF082025002

• Labelled Content: 10 mg
• Assay Content: 10.22 mg
• Purity: greater than 99.8 percent
• Identification by FTIR Spectrum: 997
• Identification by HPLC Retention Time: 0.99
• Bacterial Endotoxins: below 0.001 EU/mg
• Total Aerobic Microbial Count: Not detected
• Total Yeast and Mold Count: Not detected

Independent elemental impurity analysis reported arsenic, cadmium, cobalt, lead, mercury, nickel and vanadium as not detected within the laboratory reporting limits.

Microbiological analysis demonstrated no detectable aerobic microorganisms together with no detectable yeast or mold growth for the analysed batch.

Together, these analytical results provide comprehensive batch-specific documentation supporting the quality, identity and consistency of the tested research material.

Identity and Purity Verification

Rather than relying solely on chromatographic purity, GF-DUAL is evaluated through multiple independent analytical techniques.

Chromatographic analysis confirmed peptide purity greater than 99.8 percent, while assay testing measured 10.22 mg of peptide. Identity was independently verified using FTIR spectrum analysis together with HPLC retention time comparison.

This combination of analytical techniques provides greater confidence in batch identity, quality and consistency than purity testing alone.

Microbiological and Endotoxin Testing

Independent microbiological analysis forms an important component of the Grail Formula quality programme.

For this production batch, Total Aerobic Microbial Count and Total Yeast and Mold Count were both reported as not detected.

Bacterial endotoxin analysis reported a result below 0.001 EU/mg, demonstrating exceptionally low endotoxin levels within the tested sample.

These analyses contribute to the comprehensive laboratory documentation supplied with each production batch.

Elemental Impurity Testing

Independent elemental impurity analysis was performed for the following elements:

• Arsenic
• Cadmium
• Cobalt
• Lead
• Mercury
• Nickel
• Vanadium

All tested elemental impurities were reported as not detected within the laboratory reporting limits.

Elemental impurity screening complements chromatographic purity, assay verification and microbiological testing to provide a comprehensive analytical profile for each production batch.

Research Applications

Within controlled laboratory environments, GF-DUAL may be utilised in experimental models involving peptide biology, receptor signalling, molecular communication and biochemical pathway investigations.

Examples of research applications include:

• Peptide biology investigations
• Receptor signalling studies
• Cellular communication research
• Molecular pathway analysis
• Comparative peptide investigations
• Biochemical regulation research
• Controlled in vitro peptide studies

These applications refer exclusively to scientific and laboratory investigation.

Grail Formula Quality

Every Grail Formula research compound undergoes comprehensive independent analytical verification before release.

Each production batch is evaluated for:

• Assay content determination
• Chromatographic purity assessment
• FTIR spectrum identification
• HPLC retention time verification
• Microbiological quality
• Bacterial endotoxin analysis
• Heavy metal screening
• Complete batch traceability

This quality programme provides researchers with transparent analytical documentation supporting reproducibility and confidence in every production batch.

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete third-party Certificates of Analysis.

Every batch is tested by Liquilabs s.r.o. Czechia using validated analytical methodologies and includes documentation covering assay content, purity, identity, microbiological quality, endotoxin analysis and elemental impurity screening.

Rather than relying on marketing claims, Grail Formula provides transparent laboratory data so researchers can review the analytical characteristics of each production batch directly.

Storage and Laboratory Handling

GF-DUAL is supplied as a lyophilized research compound and should be stored according to appropriate laboratory procedures to preserve stability and analytical integrity.

Preparation and handling should only be performed within suitable laboratory environments by qualified personnel following established research protocols.

Research Use Limitation

• Intended solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for self-administration
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not intended to prevent or treat any disease
• Not permitted for clinical administration
• For research use only

GF-DUAL 10 mg is supplied exclusively as a research compound. All analytical information is derived from the batch-specific Certificate of Analysis and is provided solely for scientific and laboratory purposes.

• Independently analysed by Liquilabs s.r.o. Czechia
• Purity greater than 99.8 % confirmed by COA
• Assay content verified at 10.22 mg
• Identity confirmed by FTIR spectrum analysis
• Identification confirmed by HPLC retention time analysis
• Bacterial endotoxin level below 0.001 EU/mg
• No detectable aerobic microbial contamination
• No detectable yeast or mold contamination
• No detectable heavy metals within laboratory reporting limits
• Complete batch-specific analytical documentation
• Research-grade peptide compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.